Alessa Fahira, Iqbal Taufiqqurrachman, Ghafur Rasyid Arifin and Lili Legiawati
University of Indonesia, Indonesia
Dr. Cipto Mangunkusumo National Central General Hospital, Indonesia
Scientific Tracks Abstracts: J Dermatol Dis
Introduction & Aim: Isotretinoin was found to be superior among other acne therapies in reducing acne lesion counts; hence
its valuable role in the treatment of acne is indisputable. While there are many comparative studies comparing the efficacy and
safety of different doses regiments, there is no systematic review assessing these studies to determine the best recommendation
for oral Isotretinoin dose regiment to treat acne vulgaris. The study aims to determine the best recommendation for oral
Isotretinoin dose regiment in the treatment of mild-moderate-severe acne vulgaris.
Method: We searched PubMed, Cochrane, Scopus, ProQuest, EBSCOHOST and Science Direct for comparative studies of
randomized controlled trials evaluating different doses regiment of oral Isotretinoin in the treatment of acne vulgaris. Data
were extracted and summarized descriptively. Five trials were identified.
Results: Across all trials, low-dose regiments were preferable in all types of acne: Considering its similar efficacy with
conventional dose and fewer occurrences of side-effects and relapse with better patientsā?? compliance and satisfaction. If
compared with other regiments of low-dose treatment, continuous low-dose regiment had the best efficacy.
Conclusion: We recommend using continuous low-dose regiments for mild-moderate-severe acne considering its efficacy,
safety, patientā??s compliance and satisfaction.
E-mail: Fahiraalessa@gmail.com
Journal of Dermatology and Dermatologic Diseases received 4 citations as per Google Scholar report